Fedwatch: How Few i...
Health Care: Drugs
Supernus Pharmaceuticals Inc (SUPN: NASDAQ)
$6.67 0.02 | 0.30%
06/18/13 - 04:00 PM ET
354.87K / 609.70K
Vol / Avg. Vol:6.61 / 6.65
Open / Prev. Close:6.50 - 6.78
Today's Range:4.45 - 16.68
52 Wk Range:-11.99%
Performance YTD:TheStreet Rating:
Portfolios with SUPN
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- UserPharma
- ContributorStocks Under-$10 Moving Hig...
Latest SUPN Headlines from TheStreet
- 5 Stocks Under $10 Triggering Breakouts 03.21.13 | 01:03 pm
- Supernus Pharmaceuticals Reports Fourth Quarter 2012 And Full Year 2012 Financial Results 03.14.13 | 04:03 pm
- Supernus Announces Year-End And Fourth Quarter 2012 Earnings Conference Call And Webcast 03.07.13 | 09:03 pm
- Supernus Launches Oxtellar XR(TM) In The United States 02.01.13 | 08:02 am
- 5 Stocks Under $10 Poised to Pop 01.24.13 | 12:01 pm
- Supernus Appoints Victor Vaughn As Senior Vice President Of Sales 01.14.13 | 07:01 pm
- Hyperion Shares Poised to Run Up Ahead of FDA Decision 12.05.12 | 08:12 am
- Short Trade: Supernus IPO Lock-Up 10.31.12 | 07:10 am
- Supernus Receives FDA Approval For Oxtellar XR(TM) In Epilepsy 10.22.12 | 07:10 am
- 5 Stocks Poised for Breakouts 10.05.12 | 01:10 pm
Press Releases for SUPN
Partner Headlines for SUPN
- UPDATE: Citigroup Initiates Supernus Pharmaceuticals at Neutral; Fully Valued - Benzinga 11.27.12 | 01:11 pm
- Pipeline Advances at Supernus - Analyst Blog - Zacks 11.26.12 | 07:11 pm
- Apollo Group SPIKES 10% to Lead These 5 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- SBA Enters MERGER Agreement and Other Stocks that Have Hit 52-Week Highs - Wall St. Cheat Sheet 06.27.12 | 10:06 am
- Morning Market Movers - Benzinga 06.26.12 | 09:06 am
